NervGen (NGEN) Reports C$80.1M Cash, Runway Through RESTORE Data in 1H 2028
NervGen reported C$80.1M in cash and cash equivalents as of September 30, 2026, versus C$22.1M on December 31, 2025. The company expects these funds to last through anticipated RESTORE topline data in 1H 2028.Material DetailsContext by AI AnalystThis is a mid-cycle clinical-stage update, with the c…